Given the association between dysadherin expression and aggressive thyroid cancers and the limited expression of dysadherin in normal cells, dysadherin could potentially serve as an additional adverse prognostic marker for thyroid cancers. The gene discussed is FXYD5; the disease is thyroid gland carcinoma.